5
155 R.A. Norman, J. Endo, Clinical Cases in Geriatric Dermatology, Clinical Cases in Dermatology, DOI 10.1007/978-1-4471-4135-8, © Springer-Verlag London 2013 Index A Acneiform rash biopsy, 134 cetuximab, EGFR, 132–133 diagnosis, 131 patient history, 131–134 treatment, 134–135 Acne vulgaris, 109 AGA. See Androgenetic alopecia Alopecia areata, 148 American Joint Committee on Cancer (AJCC), 86 Anaplastic large cell lymphoma (stage IIE) cause of, 52 diagnosis, 51, 53 NHL, 52 patient history, 51, 52 symptoms, 52 treatment, 53 Androgenetic alopecia (AGA) diagnosis, 146 differential diagnoses, 148 pathophysiology, 147 patient history, 145, 146 risk marker, 147 treatment, 147 Angioedema, 139 Angiosarcoma diagnosis, 47 lymphedema-related vs. non-lymphedema- related, 48 patient history, 47, 48 prognostic factor, 49 treatment, 48–49 Annular sarcoidosis, 122 Atrophie blanche, 127 Atypical fibroxanthoma diagnosis, 56–57 epidemiologic evidence, 56 low-grade sarcoma, 56 patient history, 55, 56 treatment, 57 B Basal cell carcinoma, 119 diagnosis, 73 patient history, 73, 74 symptoms, 73–74 treatment, 74 B-cell non-Hodgkins lymphomas, 53 Bowen’s disease, 40 Breast metastasis diagnosis, 77 patient history, 77, 78 surgery and chemotherapy, 78

Index [link.springer.com]978-1-4471-4135-8/1.pdf · Index 159 Superficial thrombophlebitis, 10 Syphilis, 148 T Telogen effluvium, 148 Tinea corporis, 35, 44, 79, 122 Tinea manuum,

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Index [link.springer.com]978-1-4471-4135-8/1.pdf · Index 159 Superficial thrombophlebitis, 10 Syphilis, 148 T Telogen effluvium, 148 Tinea corporis, 35, 44, 79, 122 Tinea manuum,

155R.A. Norman, J. Endo, Clinical Cases in Geriatric Dermatology, Clinical Cases in Dermatology,DOI 10.1007/978-1-4471-4135-8, © Springer-Verlag London 2013

Index

AAcneiform rash

biopsy, 134cetuximab, EGFR, 132–133diagnosis, 131patient history, 131–134treatment, 134–135

Acne vulgaris, 109AGA. See Androgenetic

alopeciaAlopecia areata, 148American Joint

Committee on Cancer (AJCC), 86

Anaplastic large cell lymphoma (stage IIE)

cause of, 52diagnosis, 51, 53NHL, 52patient history, 51, 52symptoms, 52treatment, 53

Androgenetic alopecia (AGA)

diagnosis, 146differential diagnoses, 148pathophysiology, 147patient history, 145, 146risk marker, 147treatment, 147

Angioedema, 139

Angiosarcomadiagnosis, 47lymphedema-related

vs. non-lymphedema- related, 48

patient history, 47, 48prognostic factor, 49treatment, 48–49

Annular sarcoidosis, 122Atrophie blanche, 127Atypical fibroxanthoma

diagnosis, 56–57epidemiologic evidence, 56low-grade sarcoma, 56patient history, 55, 56treatment, 57

BBasal cell carcinoma, 119

diagnosis, 73patient history, 73, 74symptoms, 73–74treatment, 74

B-cell non-Hodgkins lymphomas, 53

Bowen’s disease, 40Breast metastasis

diagnosis, 77patient history, 77, 78surgery and chemotherapy, 78

Page 2: Index [link.springer.com]978-1-4471-4135-8/1.pdf · Index 159 Superficial thrombophlebitis, 10 Syphilis, 148 T Telogen effluvium, 148 Tinea corporis, 35, 44, 79, 122 Tinea manuum,

156 Index

Brittle nailsdiagnosis, 151nutritional deficiencies, 152pathophysiology, 152patient history, 151, 152treatment, 153

Bullous pemphigoidclinical appearance, 5diagnosis, 4immunoblistering disease, 4patient history, 3–4skin biopsy, 97urticarial phase, 139

Bullous scabies, 6

CCandidiasis

Candida albicans, 42cutaneous fungal infections, 42diagnosis, 41irritant intertrigo, 43paronychia, 42patient history, 41, 42symptoms, 43thrush, 42treatment, 43

Cellulitis, 44Centers for Disease Control

(CDC), 30Condyloma accuminata

diagnosis, 37gardasil, 40patient history, 37–39preventive/treatment measures,

38–39warts, HPV, 37–39

Condylomata lata of secondary syphilis, 40

Contact dermatitis, 78allergic and irritant causes, 96degree of vesiculation, 96diagnosis, 95history and skin

examination, 97lichenification and crusting, 119patch testing, 97

patient history, 95, 96risk factor, 97treatment, 97venous stasis (gravitational)

ulcer, 126Cutaneous T-Cell lymphoma

(CTCL), 68

DDisseminated superficial actinic

porokeratosis (DSAP), 122

EEczema, 44, 64Epidermolysis bullosa acquisita

(EBA), 5–6Erythema annulare

centrifugum, 123Erythema multiforme, 139Erythema nodosum, 10

FFibrosarcoma, 49Fixed drug eruption, 82

GGiant cell tumor, tendon sheath

diagnosis, 90localized and diffuse types, 91patient history, 89, 90skin biopsy, 89, 91texture, 90treatment, 91

Gougerot-Blum disease, 115Granuloma annulare, 122

HHair transplant, 148Herpes zoster

diagnosis, 27immunocompromised patient

considerations, 30

Page 3: Index [link.springer.com]978-1-4471-4135-8/1.pdf · Index 159 Superficial thrombophlebitis, 10 Syphilis, 148 T Telogen effluvium, 148 Tinea corporis, 35, 44, 79, 122 Tinea manuum,

157Index

multiple contiguous/ noncontiguous dermatomes, 28

patient history, 27–29postherpetic neuralgia, 28risk factors, 28varicella zoster virus, 27

Human papilloma virus (HPV), 37–39

Hypertensive (arterial) ulcers, 126–127

IIchthyosis vulgaris, 101Immunoblistering disease, 4Impetigo, 79Infectious ulcers, 127Inflammatory ulcers, 127Intertriginous candidiasis, 43

KKeratosis pilaris, 109

LLentigo maligna

diagnosis, 81patient history, 81, 82slow-growing variant, 82symptoms, 81–82treatment, 82

Lichen aureus, 115Lichen planus, 40Lupus erythematosus, 109

MMajocchi’s disease, 114Malignant melanoma, 49Mal perforans, 127Mammary Paget’s disease

cytopathology, 64diagnosis, 63, 64mammogram

and biopsy, 64

patient history, 63, 64treatment, 65

Median nail dystrophy, 153Merkel cell carcinoma, stage I

diagnosis, 59Mohs surgery, 60patient history, 59, 60polyomavirus, 60prognosis, 60treatment algorithm, 60

Metastatic carcinoma, 53Mycosis fungoides (MF)

CTCL, 68diagnosis, 67, 69erythrodermic stage, 69pathogenesis, 68patient history, 67–70prognosis, 69treatment, 69–70tumor stage, 68–69

NNeoplastic ulcers, 127Non-Hodgkin lymphoma

(NHL), 52Nummular dermatitis, 100

OOnychomycosis, 153

PPalmoplantar pustulosis, 104Pemphigus vulgaris, 5Pigmented basal cell carcinoma, 83Pigmented villonodular synovitis

(PVNS), 91Polyarteritis nodosa

causes, 10diagnosis, 9patient history, 9ulcerations, 10

Porokeratosisdiagnosis, 121DSAP, 122

Page 4: Index [link.springer.com]978-1-4471-4135-8/1.pdf · Index 159 Superficial thrombophlebitis, 10 Syphilis, 148 T Telogen effluvium, 148 Tinea corporis, 35, 44, 79, 122 Tinea manuum,

158 Index

Porokeratosis (cont.)keratinization, benign clonal

disorder, 122patient history, 121, 122treatment, 122

Post-inflammatory hyperpigmentation, 82–83

Pressure necrosis, 78Prurigo nodularis

butterfly sign, 118diagnosis, 117patient history, 117, 118treatment, 118

Psoriasis, 35, 44diagnosis, 103palmoplantar pustulosis, 104patient history, 103, 104pustular, 105sebopsoriasis, 104treatment, 105

Psoriatic nail disease, 153Pterygium, 153Pustular psoriasis, 97PVNS. See Pigmented

villonodular synovitisPyoderma gangrenosum

causes, 14diagnosis, 13patient history, 13, 14periulcer erythema, 10

Pyogenic granuloma, 49

RRheumathoid vasculitis, 14Rhinophyma, 108Rosacea

causes, 108diagnosis, 108erythematotelangiectatic

type, 108papulopustular type, 108patient history, 107, 108psychological

conditions, 108treatments, 109

SScabies

clinical examination, 24diagnosis, 23, 24mupirocin/oral

anti-infectives, 25oral antihistamines, 25oral ivermectin, 25patient history, 23, 24permethrin, 25pruritus, 25risk factors, 24Sarcoptes scabiei mite, 23skin scraping, 119topical/oral

glucocortiocsteroids, 25treatment, 24–25

SCC. See Squamous cell carcinomaSchamberg’s disease

diagnosis, 111patient history, 111–114purpuric dermatosis, 114

SCLE. See Subacute cutaneous lupus erythematosus

Sebopsoriasis, 104Seborrheic dermatitis, 109Shingles. See Herpes zosterSmall plaque parapsoriasis, 35Solar lentigo, 82Squamous cell carcinoma (SCC),

14, 119appearance, 86diagnosis, 85–87patient history, 85, 86risk factor, 86sun-exposed skin areas, 86treatment, 87

Stasis dermatitis, 101, 115Subacute cutaneous lupus

erythematosus (SCLE)antinuclear antibodies, 18diagnosis, 17drug-induced lupus, 18patient history, 17, 18topical steroids and

antimalarials, 19

Page 5: Index [link.springer.com]978-1-4471-4135-8/1.pdf · Index 159 Superficial thrombophlebitis, 10 Syphilis, 148 T Telogen effluvium, 148 Tinea corporis, 35, 44, 79, 122 Tinea manuum,

159Index

Superficial thrombophlebitis, 10Syphilis, 148

TTelogen effluvium, 148Tinea corporis, 35, 44, 79, 122Tinea manuum, 97Tinea versicolor

diagnosis, 33, 34location, 34Malassezia furfur, 34patient history, 33–35treatment, 34–35

Traumatic/factitial ulcers, 127Trichotillomania, 148

UUrticaria

allergic/nonallergic mast cell degranulation, 138

biopsy, 138causes, 138diagnosis, 137patient history, 137–139

peripheral blanching and dermographism, 137

prognosis, 140treatment, 139–140

Urticarial vasculitis, 139

VVenous stasis

(gravitational) ulcercontact dermatitis, 126diagnosis, 125etiology, 126panniculitis, 126patient history, 125, 126

Vitiligo, 35

XXerosis

“crazy pavement” appearance, 99

diagnosis, 99patient history, 99, 100prognosis, 102treatment, 101